Comparison of Three Triple Therapies in the Eradication of Helicobacter pylori
The eradication of Helicobacter pylori infection has proved difficult. As with other chronic infections, evasion of the immune response may be a major factor contributing towards the persistence of infection and the difficulty in eradication with antimicrobials. Although H. pylori can be suppressed with single antibiotic therapy, recrudesence of the infection following the cessation of treatment is the rule [1, 2]. This occurs despite a high in vitro sensitivity of H. pylori to various single antibiotics  and apparent therapeutic mucosal antibiotic levels [4, 5]. The resistence to antibiotic therapy may be due to (a) diminished antibiotic activity in the acid environment of the stomach; (b) the development of resistent forms of H. pylori; and (c) the antibiotics not reaching the bacteria in its protected niche under the mucous layer. It is obviously difficult to determine if an antibiotic has reached a precise niche ; however, adequate therapeutic mucosal antibiotic levels appear to have been achieved. This would seem to suggest that lack of assistance from an immune response may be a significant factor in failure of single antibiotic therapy.
KeywordsTriple Therapy Eradication Rate Urea Breath Test Rapid Urease Testing Triple Therapy Regimen
Unable to display preview. Download preview PDF.
- 1.Langenberg W, Rauws EAJ, Houthoff HJ, Oudbier JH, Widjojokosumo A, Tytgat GJN, Zanen HC (1987) Follow up of Campylobacter pyloridis associated gastritis after treatment with amoxacillin and/or colloidal bismuth subcitrate. In: Kaijser B, Falsen E (eds) Campylobacter, Vol 4. University of Göteborg, Göteborg, pp 366–367Google Scholar
- 2.Hirschl AM, Pletschette M (1989) Antibiotic treatment of Campylobacter pylori infection. In: Rathbone BJ, Heatly RV (eds) Campylobacter pylori and gastroduodenal disease. Balckwell, Oxford, pp 217–224Google Scholar
- 5.Westblom TU, Duriex DE, Madan E, Belshe RB (1990) Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens. Antimicrob Agents Chemother 34/1:25–28Google Scholar
- 6.Borody T, Cole P, Noonan S, Morgan A, Ossip G, Maysey J, Brandi S (1988) Long term Campylobacter recurrence post-eradication. Gastroenterology 94 : A43.Google Scholar
- 9.Glupczynski Y, Lubbe M, Vanderlinden MP, Nyst JF (1989) Lack of antibiotic compliance in patients treated for Campylobacter pylori — associated gastritis. Am J Gastroenterol 84/9:1060–1064Google Scholar
- 15.Logan RPH, Gummett PA, Poison RJ, Walker MM, Baron JH, Misiewicz J (1990) The recurrence of H. pylori in relation to duodenal ulcer. Gastroduodenal pathology and Helicobacter pylori. Rev Esp Enferm Dig 78 [Supp 1]: 72Google Scholar
- 16.Otto G, Fox JG, Wu PY, Taylor NS (1990) Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapy. Antimicrob. Agents Chemother 34/6:1232–1236Google Scholar
- 17.Gottfried MR, Washington K, Harrell LJ (1990) Helicobacer pylori-like microorganisms and chronic active gastritis in ferrets. Am J Gastroenterol 85/7:813–818Google Scholar
- 19.Radin MJ, Eaton KA, Krakowka S, Morgan DR, Lee A, Otto G, Fox J (1990) Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun 58/8:2606–2612Google Scholar
- 20.Engstrand L, Gustavsson S, Jorgensen A, Schwan A, Scheynius A (1990) Inoculation of barrier-born pigs with Helicobacter pylori: a useful animal model for gastritis type B. Infect Immun 58/6:1763–1768Google Scholar